Skip to main content

Advertisement

SpringerLink
Log in

In-hospital mortality reduction in systemic lupus erythematosus over 2 decades varied by patient sex and age

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

These data are easily available from the Agency for Healthcare Research and Quality (AHRQ’s) “Healthcare Cost and Utilization Project (HCUP)” and can be obtained after completing an on-line Data Use Agreement training session and signing a Data Use Agreement. The contact information for requesting the data is as follows: HCUP Central Distributor Phone: (866) 556-4287 (toll-free); Fax: (866) 792-5313; E-mail: HCUPDistributor@ahrq.gov.

Abbreviations

NIS:

National Inpatient Sample

SLE:

systemic lupus erythematosus

ICD-9-CM:

International Classification of Disease, ninth revision, common modification

References

  1. Tselios K, Gladman DD, Sheane BJ, Su J, Urowitz M (2019) All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013). Ann Rheum Dis 78(6):802–806. https://doi.org/10.1136/annrheumdis-2018-214802

    Article  PubMed  Google Scholar 

  2. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 42(1):46–50. https://doi.org/10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2

    Article  CAS  PubMed  Google Scholar 

  3. Krishnan E, Hubert HB (2006) Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis 65(11):1500–1505. https://doi.org/10.1136/ard.2005.040907

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Singh JA, Cleveland JD (2020) Declining in-hospital mortality gap between systemic lupus erythematosus (SLE) and non-SLE hospitalisations: a national study. Ann Rheum Dis:annrheumdis-2020-218386. https://doi.org/10.1136/annrheumdis-2020-218386

  5. Bernatsky S, Linehan T, Hanly JG (2011) The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol 38(8):1612–1616. https://doi.org/10.3899/jrheum.101149

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

I thank John Cleveland, MS, of the University of Alabama at Birmingham for his assistance in statistical analyses.

Funding

This material is the result of work supported by research funds from the Division of Rheumatology at the University of Alabama at Birmingham (from the endowed professorship that Dr. Singh holds) and the resources and use of facilities at the Birmingham VA Medical Center, Birmingham, AL, USA.

Author information

Authors and Affiliations

  1. Medicine Service, VA Medical Center, 700 19th St S,, Birmingham, AL, 35233, USA

    Jasvinder A. Singh

  2. Department of Medicine at School of Medicine, University of Alabama at Birmingham, 510 20th Street South, Birmingham, AL, 35294, United States

    Jasvinder A. Singh

  3. Division of Epidemiology at School of Public Health, University of Alabama at Birmingham, 1720 Second Ave. South, Birmingham, AL, 35294-0022, USA

    Jasvinder A. Singh

  4. University of Alabama at Birmingham, Faculty Office Tower 805B, 510 20th Street S, Birmingham, AL, 35294-0022, USA

    Jasvinder A. Singh

Authors
  1. Jasvinder A. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JAS: Study conception and design, development of study protocol, review of statistical analyses, writing the first draft of the manuscript, critical revisions and submission of the manuscript, and approval of the final manuscript version.

Corresponding author

Correspondence to Jasvinder A. Singh.

Ethics declarations

Conflict of interest

JAS has received consultant fees from Crealta/Horizon, Medisys, Fidia, UBM LLC, Trio Health, Medscape, WebMD, Clinical Care options, Clearview healthcare partners, Putnam associates, Focus forward, Navigant consulting, Spherix, Practice Point communications, the National Institutes of Health and the American College of Rheumatology. JAS owns stock options in Vaxart pharmaceuticals and Charlotte’s Web Holdings, Inc. JAS previously owned stock options in Amarin, Viking, and Moderna pharmaceuticals. JAS is on the speaker’s bureau of Simply Speaking. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 12 companies. JAS serves on the FDA Arthritis Advisory Committee. JAS is the chair of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS previously served as a member of the following committees: member, the American College of Rheumatology’s (ACR) Annual Meeting Planning Committee (AMPC) and Quality of Care Committees, the Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee and the co-chair of the ACR Criteria and Response Criteria subcommittee.

Ethical approval and consent to participate

The University of Alabama at Birmingham’s Institutional Review Board approved this study and waived the need for informed consent for this database study. All investigations were conducted in conformity with ethical principles of research.

Disclaimer

The funding body did not play any role in design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.

“The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.”

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 1

(DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, J.A. In-hospital mortality reduction in systemic lupus erythematosus over 2 decades varied by patient sex and age. Clin Rheumatol 40, 1201–1203 (2021). https://doi.org/10.1007/s10067-020-05563-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-020-05563-w

Search

Navigation